Sally A1C (A1C): Uses, Supply and Risks

Sally A1C (A1C) is a crypto token issued on Base and associated with a metabolic-health AI agent concept. The project describes Sally as a personal guide intended to help people understand metabolic health and build habits around exercise, eating and stress management, with particular attention to A1C optimization. Its description also says that health goals should be pursued under professional guidance.

That description explains the project’s health focus, but it does not establish that the token itself provides medical services or that Sally can diagnose, treat or prevent disease. Nor does public sources specify a launch date or explain whether the AI agent is available as a working product. A1C is therefore best understood as a token linked to a stated health-agent concept, rather than as a substitute for clinical care. Anyone with questions about blood sugar or other health markers should speak with a qualified health professional.

The project presents Sally as an AI guide for metabolic health, but the token’s specific role is not publicly established. It does not explain whether A1C is used to pay for access, reward users, govern a protocol, or perform another function. Those uses should not be assumed simply because the project describes an AI agent.

Before interacting with the token or any related app, look for clear, current documentation explaining what A1C holders can do and whether the token is required for any product feature. Confirm that you are using the project’s genuine channels and the correct Base token contract; a name or ticker alone cannot identify a token reliably. If the project’s utility or product status is unclear, treat A1C as a speculative crypto asset, not as a claim on healthcare services or a promise of future access.

A1C has a maximum and total supply of 21 million tokens, with 21 million reported as circulating. That means the stated supply figures show no additional tokens beyond the current total, although holders should verify contract details and any supply-control mechanisms before relying on those figures.

As of 2026-11-05, A1C traded at about $0.032, with a market capitalization of about $665,000 and reported 24-hour trading volume of about $3,400. These figures can change quickly and should be treated as a dated snapshot, not a valuation forecast. The token’s reported price history also includes large fluctuations, so a low market capitalization or limited trading activity should not be mistaken for lower risk. Thin trading can make it harder to buy or sell at a desired price, and displayed prices may not reflect what a transaction can actually obtain.

A1C is reported as issued on Base, an Ethereum layer-2 network. It is not listed as the native token of a chain. To hold or transfer it, you would need a wallet that supports Base and the correct A1C token contract. Check the network and contract carefully before sending funds; tokens with similar names or symbols may be unrelated.

A1C carries the risks common to small crypto assets, including sharp price changes, limited liquidity, smart-contract vulnerabilities and loss of access through a compromised wallet or misplaced recovery phrase. The stated health focus adds another important boundary: token ownership does not provide medical advice, and project language about potential health benefits is not a substitute for evidence or care from a qualified professional. For self-custody, protect your recovery phrase offline, never share it, and be cautious of unsolicited messages or sites asking you to connect a wallet. Consider the possibility of losing the full amount you choose to expose to crypto risks.